Skip to main content

Zurampic News

FDA Approves Duzallo (lesinurad and allopurinol) for Hyperuricemia in Patients with Uncontrolled Gout

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 21, 2017-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced Duzallo was approved by the U.S. Food and Drug Administration (FDA) as a once-daily...

FDA Approves Zurampic (lesinurad) to Treat High Blood Uric Acid Levels Associated with Gout

December 22, 2015 – The U.S. Food and Drug Administration today approved Zurampic (lesinurad) to treat high levels of uric acid in the blood (hyperuricemia) associated with gout, when used in...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Gout

Zurampic patient information at Drugs.com